224 related articles for article (PubMed ID: 25381723)
1. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
Pabinger I; Ay C; Dunkler D; Thaler J; Reitter EM; Marosi C; Zielinski C; Mannhalter C
J Thromb Haemost; 2015 Jan; 13(1):17-22. PubMed ID: 25381723
[TBL] [Abstract][Full Text] [Related]
2. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
[TBL] [Abstract][Full Text] [Related]
3. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
Eichinger S; Weltermann A; Mannhalter C; Minar E; Bialonczyk C; Hirschl M; Schönauer V; Lechner K; Kyrle PA
Arch Intern Med; 2002 Nov; 162(20):2357-60. PubMed ID: 12418950
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
5. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden mutation and high FVIII are associated with an increased risk of VTE in women with breast cancer during adjuvant tamoxifen - results from a prospective, single center, case control study.
Kovac M; Kovac Z; Tomasevic Z; Vucicevic S; Djordjevic V; Pruner I; Radojkovic D
Eur J Intern Med; 2015 Jan; 26(1):63-7. PubMed ID: 25592075
[TBL] [Abstract][Full Text] [Related]
7. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
10. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
Kovac M; Mikovic D; Antonijevic N; Rakicevic L; Djordjevic V; Radojkovic D; Elezovic I
J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
[TBL] [Abstract][Full Text] [Related]
11. A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers.
Mingozzi F; Legnani C; Lunghi B; Scanavini D; Castoldi E; Palareti G; Marchetti G; Bernardi F
Thromb Haemost; 2003 Jun; 89(6):983-9. PubMed ID: 12783110
[TBL] [Abstract][Full Text] [Related]
12. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.
Heraudeau A; Delluc A; Le Henaff M; Lacut K; Leroyer C; Desrues B; Couturaud F; Tromeur C
PLoS One; 2018; 13(5):e0194973. PubMed ID: 29775482
[TBL] [Abstract][Full Text] [Related]
14. Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis.
Castaman G; Tosetto A; Ruggeri M; Rodeghiero F
Br J Haematol; 1999 Jul; 106(1):232-6. PubMed ID: 10444192
[TBL] [Abstract][Full Text] [Related]
15. [Activated protein C resistance and factor V Leiden: clinical interest].
Guermazi S; Znazen R
Pathol Biol (Paris); 2011 Oct; 59(5):281-5. PubMed ID: 19896782
[TBL] [Abstract][Full Text] [Related]
16. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
[TBL] [Abstract][Full Text] [Related]
17. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
18. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
[TBL] [Abstract][Full Text] [Related]
19. Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes.
Segers O; Simioni P; Tormene D; Bulato C; Gavasso S; Rosing J; Castoldi E
J Thromb Haemost; 2012 Jan; 10(1):73-80. PubMed ID: 22044617
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]